BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor
Amarantus BioSciences, Inc. Effects Capital Restructuring In Anticipation Of National Exchange Listing 5/22/2015
CEL-SCI (CVM) Prices Up To $16 Million Public Offering Of Common Stock And Warrants 5/22/2015
Valeant (VRX) Chief Calls Recent Biotech M&A "Bit of a Bubble" 5/22/2015
Karolinska Development AB's Annual General Meeting 2015 5/21/2015
Agenus (AGEN) Announces Pricing Of Its Public Offering Of Common Stock 5/21/2015
Dicerna (DRNA) Announces Pricing Of Follow-On Offering Of Common Stock 5/21/2015
Fate Therapeutics (FATE) Announces Pricing Of Public Offering Of Common Stock 5/21/2015
Quintiles Transnational Corp. Announces Closing Of Secondary Public Offering And Repurchase Of Common Stock 5/20/2015
Helix Biopharma (TSX:HBP) Retains The Trout Group As Investor Relations Advisor 5/20/2015
Galapagos (GLPG.BR) Announces Capital Increase 5/20/2015
Portage Biotech Announces Proposed Private Placement 5/20/2015
Valeant (VRX) Announces 2015 Annual Meeting Results 5/20/2015
Momenta (MNTA) Announces Pricing Of Public Offering Of Common Stock 5/20/2015
CohBar Announces Commencement Of Trading On The OTCQX Marketplace 5/20/2015
BioSpace (DHX) Temperature Poll: Will Mylan (MYL) Buy Teva (TEVA), As Predator Becomes Prey? 5/19/2015
Momenta Pharmaceuticals, Inc. (MNTA) Announces Proposed Public Offering Of Common Stock 5/19/2015
Billionaire Doubles Down On Valeant (VRX) 5/19/2015
Pluristem Therapeutics (PSTI) To Conduct Conference At Tel Aviv Stock Exchange To Review Regulatory Progress And Company Strategy 5/19/2015
Fate Therapeutics (FATE) Announces Proposed Public Offering Of Common Stock 5/19/2015
Lucideon (Formerly Known As CERAM) To Host Free Seminar – "Sampling Best Practice For Improved Business Performance" – 12 June 2015 5/19/2015
Citi Appointed Depositary Bank For Adaptimmune’s ADR Programme 5/19/2015
Dicerna (DRNA) Announces Follow-On Public Offering Of Common Stock 5/19/2015
NeuroVive: NeuroVive Announces Prospectus Regarding Admission To Trading Of New Shares 5/19/2015
Easton Pharmaceuticals (OP: EAPH) Letter To Shareholders 5/19/2015
Pfizer (PFE) Invites Public To View And Listen To Webcast Of June 2 Conference Call With Analysts To Review Oncology Business And ASCO Data Presentations 5/19/2015
GW Pharma (GWPH) Announces Full Exercise Of Underwriters' Option To Purchase Additional American Depositary Shares 5/18/2015
Bacterin International, Inc. Sets Annual Meeting And Record Dates 5/18/2015
AbbVie (ABBV) Extends Exchange Offer To Acquire Pharmacyclics (PCYC) 5/18/2015
Galapagos (GLPG.BR) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 5/18/2015
Akorn, Inc. (AKN) Receives NASDAQ Delinquency Notice 5/18/2015
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/18/2015
Baxter International (BAX) And Baxalta Highlight Business Strategies At Investor Conferences 5/18/2015
BioInvent (BOVNF): BioInvent’s Rights Issue Oversubscribed 5/18/2015
Atossa Genetics, Inc. (ATOS) To Host Conference Call Today, Monday, May 18, 2015 At 4:30pm Eastern Time To Provide Company Update 5/18/2015
Telesta Therapeutics Publishes Its Nine Month Financial Results To March 31, 2015 And Provides Corporate Updates 5/15/2015
INC Research, Inc. (INCR) Completes Secondary Offering, Stock Repurchase And Debt Refinancing; Updates 2015 Business Outlook 5/15/2015
Amgen (AMGN) Announces Voting Results Of Annual Meeting Of Stockholders 5/15/2015
Galectin Therapeutics To Webcast Corporate Update Following Annual Meeting Of Stockholders 5/15/2015
CymaBay Therapeutics To Ring The Nasdaq Stock Market Closing Bell 5/15/2015
Tekla Life Sciences Investors Declared Stock Distribution 5/15/2015
Cystic Fibrosis Biotech Nivalis Therapeutics Files for $60 Million IPO 5/14/2015
Hikma Pharmaceuticals (HIK.L) Release: AGM Trading Update 5/14/2015
Cipher Pharma (DND.TO) Reports Voting Results From Annual And Special Meeting Of Shareholders 5/14/2015
Dow Announces Results From Annual Stockholder Meeting 5/14/2015
Agilent Technologies Inc. (A) To Host Webcast Of Analyst And Investor Meeting 5/14/2015
Quintiles (Q) Announces Pricing Of Secondary Public Offering 5/14/2015
Spectrum Pharmaceuticals, Inc. (SPPI) Commits To Review Shareholder Proposal 5/14/2015
Emergent BioSolutions (EBS) To Hold Annual Meeting Of Stockholders Thursday May 21, 2015 At 9:00 AM Eastern; Webcast Will Be Available 5/14/2015
Dow Chemical  (DOW) Announces Results From Annual Stockholder Meeting 5/14/2015
A Battle is Brewing Between Keryx (KERX)'s Largest Backer and Short Investors 5/13/2015
aTyr Pharma Announces Closing Of Initial Public Offering 5/13/2015
Neurocrine Biosciences, Inc. (NBIX) To Host Analyst And Investor Day In New York City On May 21, 2015 5/13/2015
Valeant (VRX) To Webcast 2015 Annual Meeting Of Shareholders 5/13/2015
TiGenix: Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 2 June 2015 5/13/2015
Report From The 2015 Annual General Meeting In Aerocrine 5/13/2015
Bristol-Myers Squibb (BMY) Announces The Pricing Terms Of Its Cash Tender Offer For Up To $500 Million Aggregate Principal Amount Of Its Outstanding Debt Securities 5/13/2015
Onxeo: Publication Of A Letter To Shareholders – May 2015 5/13/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 5/12/2015
Eli Lilly (LLY) Announces Cash Tender Offer For Up To $1.6 Billion Aggregate Principal Amount Of Its Outstanding Debt Securities And The Redemption Of Its 6.57% Notes Due 2016 5/12/2015
LEERINK Partners Expands Investment Banking Franchise 5/12/2015
Bristol-Myers Squibb (BMY) Announces The Early Results Of Its Cash Tender Offer For Up To $400 Million Aggregate Principal Amount Of Its Outstanding Debt Securities; Increases The Maximum Amount Of The Tender Offer 5/12/2015
Skyepharma PLC (SKYEF) AGM Trading Update 5/12/2015
Moberg Pharma AB (Formerly known as Moberg Derma): Bulletin from Moberg Pharma’s Annual General Meeting 2014 5/12/2015
MYOS (MYOS) To Host Conference Call To Discuss Quarterly Update And Management Highlights 5/12/2015
Antares Pharma, Inc. (ATRS) Announces Closing Of Public Offering Of Common Stock 5/12/2015
BioDelivery Sciences International (BDSI) Provides Corporate Update and Reports First Quarter 2015 Financial Results 5/11/2015
BioScrip (BIOS) Announces Proposal To Commence Exchange Offer 5/11/2015
GenSpera Provides Corporate Update 5/11/2015
M-Pharmaceutical - Shareholder Update 5/11/2015
Acasti Pharma Receives Extension to Regain Compliance With NASDAQ Minimum Bid Price Rule 5/11/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 5/11/2015
HEALTHSOUTH Declares Dividend On Common Stock 5/8/2015
China Cord Blood Corporation Receives Notice Of Transactions Regarding Its 7% Senior Convertible Notes Due 2017 Held By Cordlife And Magnum And Its Ordinary Shares Held By CordLife Ltd. 5/8/2015
Celator Pharmaceuticals, Inc. Announces Business Update And First Quarter 2015 Financial Results 5/8/2015
Aldeyra Therapeutics (ALDX) Announces Pricing Of Follow-On Public Offering Of Common Stock 5/8/2015
Aceto Corporation Board Of Directors Declares Quarterly Cash Dividend 5/8/2015
Provectus Biopharmaceuticals Inc. Updates Market On Business Developments 5/8/2015
Manhattan Scientifics, Inc. Issues Letter From The New President Of Its Senior Scientific Subsidiary 5/8/2015
Golden Meditech Proposes To Purchase CCBC Convertible Notes Held By Magnum And CCBC Convertible Notes And CCBC Shares Held By CGL 5/8/2015
Bulletin From Annual General Meeting In Recipharm AB 5/8/2015
Two Under-the-Radar Updates Pfizer (PFE) Investors Need to Know About 5/7/2015
aTyr Pharma Announces Pricing Of Initial Public Offering 5/7/2015
IMRIS Announces Postponement Of Its Annual Meeting Of Shareholders And Release Of First Quarter 2015 Financial Results And Conference Call 5/7/2015
Kythera (KYTH) Grants Stock Options Under Inducement Program 5/7/2015
Asterias Biotherapeutics To Host Investor Meeting To Review Clinical Development Strategy For AST-OPC1 In Spinal Cord Injury 5/7/2015
Affimed Therapeutics AG (AFMD) Announces Pricing Of Public Offering Of Common Stock 5/7/2015
GENFIT (ALGFT) Announces Its Turnover And Cash Situation As Of March 31, 2015 5/7/2015
Zivo Bioscience, Inc. Announces Increase In Credit Facility From Primary Lender And Notice Of Convertible Debt Conversion 5/7/2015
Stevia First Corp. Announces $1.5 Million Private Placement With Institutional Investors 5/7/2015
Horizon Pharma (HZNP) Announces Results Of Tender Offer 5/7/2015
Edwards Lifesciences (EW) To Webcast Annual Meeting Of Stockholders 5/7/2015
INC Research, Inc. (INCR) Announces Pricing Of Secondary Offering 5/7/2015
GENFIT (ALGFT): Ordinary General Shareholders’ Meeting Of June 3, 2015 – Availability Of Preparatory Documents 5/7/2015
pSivida (PSDV)'s Drug Delivery Technology Business Model Draws Comparison to Regeneron (REGN) Blockbuster Success 5/6/2015
IDEXX Laboratories, Inc. (IDXX) Announces Two-For-One Stock Split And Increase In Share Repurchase Program 5/6/2015
GW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Raising Approximately $179.2 Million On The NASDAQ Global Market 5/6/2015
Antares Pharma, Inc. (ATRS) Announces Pricing Of Public Offering Of Common Stock 5/6/2015
Paratek Pharmaceuticals, Inc. Announces Closing Of Common Stock Offering 5/6/2015
Advaxis, Inc. Announces Closing Public Offering Of Common Stock With Gross Proceeds Totaling $53.2 Million 5/6/2015
Galapagos (GLPG.BR) Announces Launch Of Proposed Global Offering 5/6/2015
Galapagos (GLPG.BR) Listed 10 Years On Euronext Amsterdam And Brussels 5/6/2015
Medivir AB (MVRBF)’s Board Of Directors Has Resolved To Repurchase Own Shares 5/6/2015
Thermo Fisher Scientific (TMO) To Host Analyst Meeting 5/6/2015
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock 5/6/2015
SV Bank Exec: New Companies Are Booming, As “Frothy” Market Looks to Novel Science 5/5/2015
Bio-Techne (TECH) Declares Dividend 5/5/2015
Aldeyra Therapeutics (ALDX) Launches Proposed Follow-On Public Offering Of Common Stock 5/5/2015
Cytori Therapeutics, Inc. (CYTX) Prices Registered Direct Offering Providing For Up To $25 Million In Equity Financing 5/5/2015
Baxter International (BAX) Declares Quarterly Dividend 5/5/2015
Cardio3 Biosciences Announces Results Of Annual Shareholder Assembly 2015 And Confirmation Of Name Change To Celyad 5/5/2015
Inovio Pharmaceuticals (INO) Closes $87.4 Million Underwritten Financing 5/5/2015
Blueprint Medicines (BPMC) Announces Closing of Initial Public Offering 5/5/2015
Kite Pharma (KITE) CEO Avoids Big Tax Bite By Exercising Options Before IPO 5/4/2015
Five Things to Take Away From Vertex (VRTX)'s Q1 5/4/2015
Stressed GlaxoSmithKline (GSK) May Put $6.1 Billion Payout on Hold As New Chairman Arrives 5/4/2015
China Cord Blood Corporation Receives Notice Of A Transaction Regarding Its 7% Senior Convertible Notes Due 2017 Held By KKR 5/4/2015
EcoScience Corporation Significantly Reduces Number Of Outstanding Common Stock 5/4/2015
Burcon Nutrascience Corp. (BU) Announces Completion Of Over-Subscribed Rights Offering 5/4/2015
Tikcro Technologies Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
Generex Biotechnology Corporation (GNBT) Announces Intention To Dividend A Portion Of Anticipated SMFI Securities To Its Stockholders Upon A Reverse Stock Split 5/4/2015
Webcast Alert: Heska Corporation (HSKA)'s Annual Meeting Of Stockholders Webcast 5/4/2015
Affimed Therapeutics AG (AFMD) Announces Proposed Public Offering Of Common Stock 5/4/2015
Macrocure (MCUR) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $25 Million Public Offering 5/1/2015
Lion Biotechnologies, Inc. Announces Pricing Of Secondary Offering Of Shares By Selling Stockholders 5/1/2015
TetraLogic Pharmaceuticals (TLOG) Announces Public Offering Of Common Stock 5/1/2015
BioAmber Inc. Announces Public Offering Of Common Stock 5/1/2015
WuXi PharmaTech Co., Ltd. Announces Receipt Of Proposal 5/1/2015
Northwest Biotherapeutics (NWBO) Rakes In $28.5 Million 5/1/2015
Quintiles (Q) Announces Proposed Offering Of $800 Million Of Senior Notes 5/1/2015
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/1/2015
NephroGenex (NRX) Announces Proposed Offering Of Common Stock 5/1/2015
Juniper Pharmaceuticals Reschedules Annual General Meeting 4/30/2015
Pfenex (PFNX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/30/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Share Purchase Agreement With Lincoln Park Capital Fund, LLC 4/30/2015
Lipocine Inc. (LPCN) Prices $30.2 Million Public Offering Of Common Stock 4/30/2015
Lipocine Inc. (LPCN) Announces Closing Of $34.8 Million Common Stock Offering 4/30/2015
Inovio Pharmaceuticals (INO) Announces Public Offering Of Common Stock 4/30/2015
StemCells (STEM) Announces Closing Of $25 Million Public Offering 4/30/2015
Advaxis, Inc. Announces Proposed Public Offering Of Common Stock 4/30/2015
Inovio Pharmaceuticals (INO) Announces Pricing Of Public Offering Of Common Stock 4/30/2015
Paratek Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of 2,860,000 Shares Of Common Stock 4/30/2015
Advaxis, Inc. Prices $53 Million Public Offering Of Common Stock 4/30/2015
DS Healthcare Group Regains Compliance With Nasdaq Listing Requirements 4/30/2015
Neptune Technologies & Bioressources Inc. Provides Business Update 4/30/2015
Invitation - Presentation Of Sobi's First Quarter 2015 4/30/2015
Bristol-Myers Squibb (BMY) Prices €1.15 Billion Of Senior Notes 4/30/2015
WuXi PharmaTech Co., Ltd. Receives $3.2 Billion Privatization Offer 4/30/2015
Helix Biopharma (TSX:HBP) Closes Additional Private Placement Financing 4/30/2015
Teva (TEVA) Sends Letter To Mylan (MYL) Board 4/30/2015
Sinovac Biotech Ltd. (SVA) Files 2014 Annual Report On Form 20-F 4/29/2015
GW Pharma (GWPH) Raises $179.2 Million NASDAQ Cash 4/29/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Extension To Regain Compliance With Nasdaq's Minimum Bid Price Rule 4/29/2015
Novogen Limited (NVGN) Completes The Private Placement Of Equity 4/29/2015
NeuroDerm Ltd. (NDRM) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 4/29/2015
ProQR Therapeutics B.V. (PRQR) Announces Annual Shareholder Meeting 4/29/2015
Sobi's Board Of Directors Postpones Annual General Meeting Of Shareholders 4/29/2015
Simulations Plus (SLP) Announces Quarterly Cash Dividend Of $0.05 Per Share 4/29/2015
Looking At Biogen (BIIB) Through Warren Buffett's Eyes 4/29/2015
Basilea Pharmaceutica (BSLN.SW) Shareholders Approve All Resolutions Proposed By The Board Of Directors At The Ordinary General Meeting Of Shareholders 4/29/2015
Quintiles (Q) Announces Proposed Refinancing Of Existing Indebtedness 4/29/2015
Golden Meditech Proposes Open Offer To Eligible Shareholders To Subscribe One Offer Share For Every Two Shares Held And To Acquire Outstanding Ordinary Shares Of China Cord Blood Corporation 4/29/2015
GW Pharmaceuticals (GWPH) Announces Proposed Public Offering Of ADSs 4/28/2015
Paratek Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock 4/28/2015
22nd Century Group, Inc. Provides Highlights From Annual Shareholder Meeting 4/28/2015
China Cord Blood Corporation Receives $512 Million Take-Private Offer 4/28/2015
Novogen Limited (NVGN) Regains Full Compliance With NASDAQ Listing Rule 4/28/2015
Syngenta AG (SYT) Annual General Meeting 4/28/2015
ERYtech Pharma Receives The EnterNext Tech 40 Label 4/28/2015
Horizon Pharma (HZNP) Announces Pricing Of Private Offering Of Senior Notes 4/28/2015
Precise Biometrics AB: Resolutions At Precise Biometrics´ Annual General Meeting 2015 4/28/2015
22nd Century Group, Inc. Provides Highlights From Annual Shareholder Meeting 4/28/2015
Bristol-Myers Squibb (BMY) Announces Cash Tender Offer For Up To $400 Million Aggregate Principal Amount Of Its Outstanding Debt Securities 4/28/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/27/2015
Pfenex (PFNX) Announces Pricing Of Follow-On Offering 4/27/2015
CytoSorbents, Inc. Issues Letter To Shareholders 4/27/2015
Telesta Therapeutics Provides Key Corporate Updates 4/27/2015
Akorn, Inc. (AKN) To Make Additional Financial Restatements 4/27/2015
INC Research, Inc. (INCR) Files Registration Statement For Secondary Offering 4/27/2015
Coronado Biosciences (CNDO) Changes Its Name To Fortress Biotech 4/27/2015
Sartorius Stedim Biotech Release: New Webinar On Faster cGMP Manufacturing Scale-up Of Biotherapeutics 4/27/2015
Acucela Provides Important Company Updates 4/27/2015
AxoGen, Inc. (AXGN) Announces 2015 Annual Shareholders’ Meeting 4/27/2015
Lipocine Inc. (LPCN) Announces Proposed Public Offering Of Common Stock 4/24/2015
StemCells (STEM) Announces Proposed Public Offering Of Common Stock And Warrants 4/24/2015
Lipocine Inc. (LPCN) Prices $30.2 Million Public Offering Of Common Stock 4/24/2015
Innocoll, Inc. (INNL) Announces Pricing Of Follow-On Offering 4/24/2015
StemCells (STEM) Announces Pricing Of Public Offering To Raise $25 Million 4/24/2015
Athersys (ATHX) To Host Shareholder Conference Call 4/24/2015
Nordic Nanovector – Share Capital Increase Registered 4/24/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 4/24/2015
SCYNEXIS, Inc. (SCYX) Announces Pricing Of Public Offering Of Common Stock 4/23/2015
Celgene (CELG) To Webcast At Upcoming Investor Conferences And Medical Meetings In May 4/23/2015
Change In BioTie Therapies Corp.' Financial Calendar 2015 4/23/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 4/23/2015
Akebia Therapeutics, Inc. (AKBA) Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/23/2015
The Nomination Committee’s Proposals To The Annual General Meeting In Karo Bio AB 4/23/2015
Pfizer (PFE) Hosts Annual Meeting Of Shareholders 4/23/2015
Horizon Pharma (HZNP) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/23/2015
RestorGenex Issues Annual Letter To Stockholders 4/23/2015